{"mainPropery":{"diseaseId":10351,"diseaseName":"Spinocerebellar ataxia type 6","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10351/spinocerebellar-ataxia-type-6","synonyms":["SCA6","Spinocerebellar ataxia 6"],"synonyms-with-source":[{"name":"SCA6"},{"name":"Spinocerebellar ataxia 6"}],"identifiers":[{"identifierType":"OMIM","identifierId":"183086"},{"identifierType":"ORPHANET","identifierId":"98758"},{"identifierType":"UMLS","identifierId":"C0752124"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":44,"resourceName":"National Ataxia Foundation","abbreviation":"","address1":"600 Highway 169 South","address2":"Suite 1725","address3":"","address4":"","address5":"","city":"Minneapolis","state":"MN","zip":"55426","country":"United States","phone":"+1-763-553-0020","tty":"","tollFree":"","fax":"+1-763-553-0167","email":"naf@ataxia.org","url":"https://ataxia.org/","freeText":""},{"resourceID":46,"resourceName":"euro-ATAXIA (European Federation of Hereditary Ataxias)","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.euroataxia.org/","freeText":""},{"resourceID":403,"resourceName":"Ataxia UK","abbreviation":"","address1":"12 Broadbent Close ","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":" N6 5JW","country":"United Kingdom","phone":"020 7582 1444 ","tty":"","tollFree":"0845 644 0606 (Helpline)","fax":"","email":"helpline@ataxia.org.uk","url":"https://www.ataxia.org.uk/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/183086' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=%22spinocerebellar+ataxia+type+6%22' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Spinocerebellar ataxia type 6. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Spinocerebellar+ataxia+6%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Spinocerebellar ataxia type 6. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1140/' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Spinocerebellar ataxia type 6. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1110,"resourceId":1792,"resourceName":"Univ Washington - testing for spinocerebellar ataxias","descriptionText":"<a href='http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf' target='_blank'>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</a> is a booklet providing information about spinocerebellar ataxia and is available as a PDF document on the University of Washington Medical Center Web site. Click on the title above to view this resource.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0752124' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022500' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1533,"resourceId":2164,"resourceName":"National Center for Biotechnology Information","descriptionText":"The <a href='https://www.ncbi.nlm.nih.gov/books/NBK22234/' target='_blank'>National Center for Biotechnology Information</a> (NCBI) was established in 1988 as a national resource for molecular biology information.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98758' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=sca6' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='https://www.merckmanuals.com/professional/neurologic-disorders/movement-and-cerebellar-disorders/cerebellar-disorders#sec16-ch221-ch221j-182' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1892,"resourceId":44,"resourceName":"National Ataxia Foundation","descriptionText":"The <a href='https://ataxia.org/neurologists-and-specialty-clinics/#AtaxiaClinics' target='_blank'>National Ataxia Foundation</a>, a nonprofit organization dedicated to improving the lives of persons affected by ataxia, provides lists of neurologists, ataxia clinics, and movement disorder clinics.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:183086' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6485,"questionText":"What is spinocerebellar ataxia type 6 (SCA6)?","answerText":"<strong>Spinocerebellar ataxia type 6</strong> (SCA6) is a neurological condition characterized by progressive problems with movement.&nbsp;Initial symptoms include&nbsp;problems with coordination and balance (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003198.htm\" target=_blank>ataxia</a>). Other early signs and symptoms include speech difficulties (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007470.htm\" target=_blank>dysarthria</a>), involuntary eye movements (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003037.htm\" target=_blank>nystagmus</a>), and double vision. Over time, individuals with SCA6 may develop loss of coordination in their arms, tremors, and uncontrolled muscle tensing (<a href=\"http://www.nlm.nih.gov/medlineplus/dystonia.html\" target=_blank>dystonia</a>). The signs and symptoms of SCA6 typically begin in a person's forties or fifties. Most people with this disorder require wheelchair assistance by the time they are in their sixties. Spinocerebellar ataxia type 6 is caused by mutations in the <span class=geneSymbol><em><a href=\"http://ghr.nlm.nih.gov/gene/CACNA1A\" target=_blank>CACNA1A</a></em></span> gene. This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> pattern.[5554]","dateModified":"2012-10-10T20:18:00"},"basicQuestions":[{"questionId":6487,"questionText":"What is the outlook for individuals diagnosed with spinocerebellar ataxia type 6 (SCA6)?","answerText":"The severity of symptoms associated with SCA6 varies, even within families. In most cases, symptoms develop in the&nbsp;forties or fifties and progress slowly.[5554][5555][5556] Over time, most individuals with SCA6 develop gait ataxia,&nbsp;loss of coordination in their arms, tremors, uncontrolled muscle tensing (<a href=\"http://www.nlm.nih.gov/medlineplus/dystonia.html\" target=_blank>dystonia</a>), and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007470.htm\" target=_blank>dysarthria</a>.[5554][5556] <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007543.htm\" target=_blank>Dysphagia</a> and choking are also common. Cognitive function is generally preserved.[5556] Most people with this disorder require wheelchair assistance by the time they are in their sixties.[5554]&nbsp;Lifespan is not usually shortened by this disease.[5555][5556] ","dateModified":"2012-10-10T20:27:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5554,"authors":"","articleTitle":"Spinocerebellar ataxia type 6","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2011","url":"http://ghr.nlm.nih.gov/condition/spinocerebellar-ataxia-type-6","dateAccessed":"2012-10-10T00:00:00"},{"referenceId":5555,"authors":"","articleTitle":"Frequently Asked Questions About Spinocerebellar Ataxia Type 6 (SCA6)","bookWebsiteJournalTitle":"National Ataxia Foundation","date":"2012","url":"http://www.ataxia.org/pdf/NAF%20Web%20Content%20Publication%20SCA6.pdf","dateAccessed":"2012-10-10T00:00:00"},{"referenceId":5556,"authors":"Gomez CM","articleTitle":"Spinocerebellar Ataxia Type 6","bookWebsiteJournalTitle":"GeneReviews","date":"2008","url":"http://www.ncbi.nlm.nih.gov/books/NBK1140/","dateAccessed":"2012-10-10T00:00:00"}]},{"questionId":6486,"questionText":"How might spinocerebellar ataxia type 6 (SCA6) be treated?","answerText":"While there is no specific treatment which can prevent of slow the progression of SCA6, there are therapies available to help manage the symptoms.[5555]&nbsp;For instance:[5556] <br>\r\n<p>&nbsp;</p>\r\n<ul>\r\n<li>Episodes of ataxia, vertigo, and sleep disorders can be treated with medication, \r\n<li>Home modifications may be made for safety and convenience, \r\n<li>Canes and walkers&nbsp;can allow for continued mobility, \r\n<li>Speech therapy and communication devices may help with <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/007470.htm\" target=_blank>dysarthria</a>, and \r\n<li>Weighted eating utensils and dressing hooks can help patients maintain independence.&nbsp;</li></ul>\r\n<p>Affected individuals should be followed annually or semiannually by a neurologist, with consultations as needed with other specialists.[5556] More detailed information related to the treatment of SCA6 can be accessed through the <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK1140/#sca6.Management\" target=_blank>GeneReviews</a> Web site.<br><br></p>","dateModified":"2012-10-10T20:30:00","resourceClassificationName":"Treatment","references":[{"referenceId":5555,"authors":"","articleTitle":"Frequently Asked Questions About Spinocerebellar Ataxia Type 6 (SCA6)","bookWebsiteJournalTitle":"National Ataxia Foundation","date":"2012","url":"http://www.ataxia.org/pdf/NAF%20Web%20Content%20Publication%20SCA6.pdf","dateAccessed":"2012-10-10T00:00:00"},{"referenceId":5556,"authors":"Gomez CM","articleTitle":"Spinocerebellar Ataxia Type 6","bookWebsiteJournalTitle":"GeneReviews","date":"2008","url":"http://www.ncbi.nlm.nih.gov/books/NBK1140/","dateAccessed":"2012-10-10T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12858,"relatedDiseaseName":"Autosomal Dominant Cerebellar Ataxias","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":6614,"relatedDiseaseName":"Hereditary ataxia","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10748,"relatedDiseaseName":"Spinocerebellar ataxia","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14705,"phenoTypeName":"Bradyopsia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13455,"phenoTypeName":"Gait ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14415,"phenoTypeName":"Gaze-evoked horizontal nystagmus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11393,"phenoTypeName":"Incoordination","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13713,"phenoTypeName":"Intention tremor","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13848,"phenoTypeName":"Postural instability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13460,"phenoTypeName":"Progressive cerebellar ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11410,"phenoTypeName":"Unsteady gait","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2366,"phenoTypeName":"Choking episodes","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10125,"phenoTypeName":"Diplopia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14233,"phenoTypeName":"Vertical nystagmus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10115,"phenoTypeName":"Blepharospasm","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13709,"phenoTypeName":"Migraine","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10550,"phenoTypeName":"Abnormal vestibulo-ocular reflex","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","percentRanges":"-"},{"phenoTypeId":10110,"phenoTypeName":"Gaze-evoked nystagmus","percentRanges":"-"},{"phenoTypeId":5308,"phenoTypeName":"Genetic anticipation","percentRanges":"-"},{"phenoTypeId":8456,"phenoTypeName":"Impaired smooth pursuit","percentRanges":"-"},{"phenoTypeId":5255,"phenoTypeName":"Progressive","percentRanges":"-"},{"phenoTypeId":14147,"phenoTypeName":"Sensory neuropathy","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Spinocerebellar_ataxia_type_6"}